NEW YORK (Reuters Health) - Human papillomavirus or HPV, which can cause cervical cancer, may also infect the anus -- but the infection appears to resolve relatively quickly, researchers report.
"This fact may help explain why anal cancer among women is so much rarer than cervical cancer," Dr. Yurii B. Shvetsov told Reuters Health.
Dr. Shvetsov of the Cancer Research Center of Hawaii, Honolulu and colleagues examined the factors associated with anal HPV infection...
Disease is more aggressive, requiring more radical treatments, study suggests
FRIDAY, March 13 (HealthDay News) -- The risk of breast cancer re-occurring is greater in women younger than 35 than it is in older women, especially if they opt for less radical treatment for the disease, a new study says.
In analyzing treatment of 652 breast cancer patients over three decades, researchers from the University of Texas M.D. Anderson Cancer Center in Houston found that younger...
ARIMIDEX Offers Women Greater Protection Against HR+ Early Breast Cancer Returning In The 1st 2 Yrs
13 Mar 2009
"Anastrozole is the only aromatase inhibitor (AI) which has now been shown to prevent recurrences in women with hormone receptor positive early breast cancer both during the initial high-risk two years after surgery, and also well beyond the completion of treatment. In breast cancer there are no guarantees and we can't predict which women will experience...
Last Updated: 2009-03-12 16:16:40 -0400 (Reuters Health)
By David Douglas
NEW YORK (Reuters Health) - Intraoperative intraperitoneal chemotherapy with cisplatin appears to be a viable approach in patients with peritoneal carcinomatosis of ovarian cancer, French researchers report in a February 9th on-line paper in the World Journal of Surgical Oncology.
"Intraperitoneal chemotherapy is usually carried out by administering the chemotherapeutics using an...
Last Updated: 2009-03-10 16:00:32 -0400 (Reuters Health)
NEW YORK (Reuters Health) - Screening for breast cancer risk in postmenopausal women, based on breast density and other factors, identifies patients at high risk who would benefit from chemoprophylaxis and lifestyle changes, according to a report in the Journal of the National Cancer Institute for March 18.
"Although mammographic screening results in decreased mortality from breast cancer, it does not reduce...
